Gordon A J, Calder A A
Br J Hosp Med. 1983 Jul;30(1):52, 54-6, 58.
When induction of labour is being considered the first step should be to assess the cervical score. If this is low, the gestational age should be confirmed since an unripe cervix is normal in earlier pregnancy and there may be a mistake in the patient's dates. If the maturity is confirmed, the choice lies between delivering the baby and waiting. Few genuine indications for induction change by waiting and increased risks may occur by postponing the date of delivery. The choice may then lie between elective caesarean section or amniotomy and intravenous oxytocin with an unripe cervix on the one hand, and cervical ripening before induction of labour on the other (Lancet, 1979). The last course has many advantages to commend it. There is still much to be learnt about cervical ripening. The success of the prostaglandins suggests that they may be the agents of choice at present. The ideal preparation would be one that could be administered vaginally to ripen the cervix without inducing uterine contractions. A major problem to date has been the absence of a commercially available PGE2 preparation for local use and this has necessitated the formulation of home-made gels and pessaries by individual hospital pharmacies. However, recently Prostin E2 vaginal tablets (each containing dinoprostone 3 mg) have been marketed and initial studies (Stewart et al, 1983) have shown promising results.
当考虑引产时,第一步应该是评估宫颈评分。如果评分较低,应确认孕周,因为在妊娠早期宫颈不成熟是正常的,患者的孕周可能有误。如果确认了成熟度,选择就在分娩和等待之间。很少有真正的引产指征会因等待而改变,推迟分娩日期可能会增加风险。那么选择可能一方面是选择性剖宫产或羊膜穿刺术并静脉滴注缩宫素(用于宫颈不成熟的情况),另一方面是在引产之前促进宫颈成熟(《柳叶刀》,1979年)。最后一种方法有很多优点值得推荐。关于宫颈成熟仍有许多有待了解的地方。前列腺素的成功表明它们目前可能是首选药物。理想的制剂应该是一种可以经阴道给药以使宫颈成熟而不引起子宫收缩的药物。迄今为止的一个主要问题是缺乏市售的局部使用的前列腺素E2制剂,这就使得各医院药房不得不自行配制凝胶剂和阴道栓剂。然而,最近前列腺素E2阴道片(每片含地诺前列酮3毫克)已上市,初步研究(斯图尔特等人,1983年)显示出了有希望的结果。